Pain lozenges and off-label marketing

So, what do pain lozenges and off-label marketing have in common? The answer is Cephalon’s Fentora — which “is used to treat breakthrough pain in adult patients with cancer (18 years of age and older) who are regularly using other opioid pain medicines around-the-clock for their constant cancer pain”. The problem, according to the US … Continue reading